The announcement from the U.S. Food and Drug Administration (FDA) to gradually phase out animal testing marks a revolutionary shift in drug development. This groundbreaking change aims to replace traditional testing methods with artificial intelligence (AI) and other advanced technologies,
The evolution of the U.S. private healthcare system is a tale of continual adaptation and innovation, shaped by market dynamics, regulatory changes, and technological advances. This comprehensive overview charts the history from the early foundations to emerging future trends in the industry. In
Patients with Inflammatory Bowel Disease (IBD) often grapple with a myriad of challenges that impede their access to timely and effective medical care. Recent studies presented at the Crohn's & Colitis Congress in 2025 have brought to light the significant barriers that insurance issues
Schrödinger, Inc., a company renowned for its computational software in drug discovery, has navigated the biotech landscape for 35 years while traditionally refraining from associating its platform with artificial intelligence (AI). This distinct approach has set Schrödinger apart from pure A
Bispecific antibodies (BsAbs) are reshaping targeted therapies with their unique ability to engage two distinct targets simultaneously. This breakthrough innovation significantly diverges from traditional monospecific monoclonal antibodies (mAbs), opening up new avenues for treating various
James Maitland is an expert in robotics and IoT applications in medicine, driven by a strong passion for leveraging technology to advance healthcare solutions. How is the pharmaceutical industry undergoing digital transformation? What role is cloud computing playing in this transformation? The
